ArticleClinical oral investigations2025
Efficacy of cryogun cryotherapy for benign oral vascular anomalies: a longitudinal study.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the efficacy and safety of cryogun cryotherapy in treating benign oral vascular anomalies (BOVAs). MATERIALS AND
methodsWe conducted a retrospective longitudinal study on patients with BOVA who underwent cryogun cryotherapy. The clinical outcomes assessed included lesion regression, recurrence, complications, and clinical predictors of prognosis.
resultsCryogun cryotherapy demonstrated high efficacy in treating BOVA in a study of 33 patients, with 97% of lesions achieving complete regression after an average of 1.64 ± 0.93 sessions (range: 1-4). Treatment outcomes were influenced by factors such as lesion morphology and anatomical location. Lesions in the buccal mucosa required more sessions compared to other anatomical sites, and exophytic lesions necessitated more sessions than flat lesions.
conclusionsCryogun cryotherapy is a safe and effective treatment option for BOVA, regardless of lesion size or location. Residual lesions can be treated successfully with additional sessions. CLINICAL RELEVANCE: Cryogun cryotherapy offers a reliable prognosis for BOVA patients and provides a cost-effective, non-invasive alternative to other treatment methods.
Indexed as
Identifiers
39904807What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.